Exhibitors at UBIFRANCE French Pavilion
Exhibitors at UBIFRANCE French Pavilion
Exhibitors at UBIFRANCE French Pavilion
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
THERALPHA<br />
2229 route des Crêtes<br />
06560 VALBONNE SOPHIA ANTIPOLIS<br />
FRANCE<br />
Phone: +33 6 25 183 239<br />
Email: david@theralpha.com<br />
Web site: www.theralpha.com<br />
Contact: David DELLAMONICA<br />
Theralpha is a specialty pharmaceutical company focused on the development and<br />
commercializ<strong>at</strong>ion of innov<strong>at</strong>ive therapies for the tre<strong>at</strong>ment pain. Our lead product,<br />
THA903, is designed to address acute pain by sublingual administr<strong>at</strong>ion. We have<br />
three additional product candid<strong>at</strong>es in preclinical development. We are advancing<br />
next gener<strong>at</strong>ion pain drugs based on scientifically valid<strong>at</strong>ed Acid Sensing Ion Channel<br />
(ASIC) p<strong>at</strong>hways. Theralpha aims to develop its pipeline to address unmet medical<br />
need in pain, a significant economic burden. We currently have four product candid<strong>at</strong>es<br />
in development.<br />
TRANSGENE<br />
Boulevard Gonthier d’Andernach<br />
Parc d’Innov<strong>at</strong>ion - CS 80166<br />
67405 ILLKIRCH Cedex - FRANCE<br />
Phone: +33 3 88 27 91 00<br />
Fax: +33 3 88 27 91 11<br />
Email: communic<strong>at</strong>ion@transgene.fr<br />
Web site: www.transgene.fr<br />
Contact: Jean-Yves BONNEFOY<br />
Transgene is a fully integr<strong>at</strong>ed biopharmaceutical company th<strong>at</strong> designs and develops<br />
cutting-edge immunotherapeutic products to tre<strong>at</strong> cancers and chronic infectious<br />
deseases. Our expertise covers all stages of product development, from research to<br />
the manufacture of clinical b<strong>at</strong>ches, and the conducting of clinical trials.<br />
64
Change language